T1	Participants 808 912	85 newly diagnosed patients with untreated essential hypertension were admitted to the outpatient clinic
T2	Participants 1030 1124	42 patients were randomized into the valsartan group and 43 patients into the amlodipine group
T3	Participants 662 789	patients with essential hypertension and to compare them with healthy volunteers in terms of their effect on energy hemostasis.
